RetinalGenix Technologies Inc.
RTGN
$4.00
$0.8025.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 472.20K | 587.10K | 547.40K | 633.90K | 573.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 589.20K | 622.10K | 567.80K | 648.30K | 586.40K |
| Operating Income | -589.20K | -622.10K | -567.80K | -648.30K | -586.40K |
| Income Before Tax | -590.50K | -623.10K | -568.80K | -649.40K | -587.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -590.50K | -623.10K | -568.80K | -649.40K | -587.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -590.50K | -623.10K | -568.80K | -649.40K | -587.30K |
| EBIT | -589.20K | -622.10K | -567.80K | -648.30K | -586.40K |
| EBITDA | -589.20K | -622.10K | -567.80K | -648.30K | -586.30K |
| EPS Basic | -0.03 | -0.03 | -0.03 | -0.04 | -0.03 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.03 | -0.03 | -0.04 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 18.75M | 18.64M | 18.58M | 18.33M | 18.52M |
| Average Diluted Shares Outstanding | 18.75M | 18.64M | 18.58M | 18.33M | 18.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |